派博傳思國際中心

標題: Titlebook: Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer; Lisa A. Newman,Jessica M. Bensenhaver Book 2015 Springer Science+Busi [打印本頁]

作者: Addiction    時間: 2025-3-21 17:38
書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer影響因子(影響力)




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer影響因子(影響力)學科排名




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer網(wǎng)絡公開度




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer網(wǎng)絡公開度學科排名




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer被引頻次




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer被引頻次學科排名




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer年度引用




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer年度引用學科排名




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer讀者反饋




書目名稱Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer讀者反饋學科排名





作者: 咯咯笑    時間: 2025-3-21 23:22
Denmark,nd noninvasive techniques. While limited randomized data are available comparing WBI and APBI in the setting of DCIS, there is a growing body of literature supporting the clinical efficacy of APBI in patients with DCIS. Further, toxicity profiles with APBI have been shown to be comparable or improve
作者: abolish    時間: 2025-3-22 01:50

作者: appall    時間: 2025-3-22 04:51

作者: 表狀態(tài)    時間: 2025-3-22 10:13

作者: 生命層    時間: 2025-3-22 16:58

作者: 生命層    時間: 2025-3-22 19:12
in the field, .Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer. is a comprehensive, state-of-the art review of the field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in breast cancer..978-1-4939-4706-5978-1-4939-2035-8
作者: 清楚說話    時間: 2025-3-23 00:59
Introduction, Evolution, and Application of the Van Nuys Prognostic Index in DCIS,
作者: 反應    時間: 2025-3-23 02:42

作者: 鬼魂    時間: 2025-3-23 06:34

作者: 使虛弱    時間: 2025-3-23 09:47
Book 2015inoma In Situ and Microinvasive/Borderline Breast Cancer. is a comprehensive, state-of-the art review of the field, and serves as a valuable resource for clinicians, surgeons and researchers with an interest in breast cancer..
作者: extinguish    時間: 2025-3-23 14:04

作者: 收養(yǎng)    時間: 2025-3-23 19:25

作者: 和平主義者    時間: 2025-3-23 23:43

作者: TATE    時間: 2025-3-24 04:19

作者: 壁畫    時間: 2025-3-24 09:29

作者: hereditary    時間: 2025-3-24 13:45

作者: 榮幸    時間: 2025-3-24 16:28

作者: set598    時間: 2025-3-24 19:15
Role of Screening Mammography in Early Detection/Outcome of Breast Cancer,g the benefit of screening mammography in the early detection of invasive breast cancer and ductal carcinoma in situ (DCIS) and the numerous recent observational and computer modeling studies that have confirmed this positive effect. Since screening began in the 1980s, mammography has been shown to
作者: interrupt    時間: 2025-3-24 23:50

作者: Aggrandize    時間: 2025-3-25 05:24
Pathology of Ductal Carcinoma In Situ: Features and Diagnostic Challenges,al excisions and needle core biopsies. It discusses the current grading system and it is focused particularly on lesions that are challenging to diagnose in daily pathology practice and that imply different treatment approaches. These topics include atypical ductal hyperplasia (ADH), pleomorphic lob
作者: Magisterial    時間: 2025-3-25 09:01

作者: 想象    時間: 2025-3-25 15:14

作者: 罵人有污點    時間: 2025-3-25 19:53
Extent and Role of Margin Control for DCIS Managed by Breast-Conserving Surgery,uvant radiation therapy. The optimal margin minimizes the potential residual disease in the breast and the risk of local recurrence while maximizing the cosmetic outcome. Studies consistently report worse local control for positive margins but are inconsistent in identifying a negative margin width
作者: 類似思想    時間: 2025-3-25 20:03
Ductal Carcinoma In Situ Treated with Breast-Conserving Surgery Alone,lished by high caliber prospective randomized trials; however, no survival benefit was seen. For this reason, some argue that radiation therapy is overtreatment for certain DCIS cases and that it is appropriate for select subgroups to be treated with breast-conserving surgery alone. There have been
作者: Adulterate    時間: 2025-3-26 02:27
DCIS Managed with BCS: Whole-Breast XRT vs. Partial Breast XRT, in situ (DCIS). Over the past few decades, several randomized trials have demonstrated a 50?% reduction in the risk of local recurrence with adjuvant radiotherapy and recent prospective studies demonstrate higher rates of local recurrence with the omission of radiotherapy even in “l(fā)ow-risk” patient
作者: ensemble    時間: 2025-3-26 08:06

作者: 留戀    時間: 2025-3-26 12:06
Role of Genetic Profiling and Recurrence Scores in Treatment Planning for DCIS,th improvements in technology, has led to the identification of large numbers of women with DCIS, many of which are detected at relatively small sizes. However, significant debate surrounds the proper management of patients with DCIS who are eligible for breast-conserving therapy. Some advocate for
作者: Headstrong    時間: 2025-3-26 14:13

作者: Nmda-Receptor    時間: 2025-3-26 18:23
Role of Postmastectomy Radiation for DCIS,asive breast cancer, the possible role of postmastectomy radiation for ductal carcinoma in situ (DCIS) remains unclear. Here, we examine the data that may be relevant to inform decisions regarding the potential indications, benefits, and side effects of postmastectomy radiation for DCIS, including d
作者: 嗎啡    時間: 2025-3-26 23:21
Monitoring and Surveillance Following DCIS Treatment, 2008; DeSantis et al., CA Cancer J Clin 64:52–62, 2014; Ernster et al., J Natl Cancer Inst 94:1546–1554, 2002). Early detection and a low breast-cancer-specific mortality (1–2?%; Ernster et al., Arch Intern Med 160:953–958, 2000) have resulted in an increasing number of patients that require clinic
作者: Saline    時間: 2025-3-27 01:35
DCIS and Hereditary Susceptibility for Breast Cancer,to invasive breast cancer, although there are molecular and cellular features that have some predictive power for the development of invasive disease. In women who carry deleterious mutations in the . or other genes, detection of DCIS is paramount, as these women are believed to be at much higher ri
作者: 閑蕩    時間: 2025-3-27 07:48

作者: neologism    時間: 2025-3-27 11:24
Women, Personas and Experiences of Self,s entity is rising, but the clinical impact of finding these premalignant lesions on overall population health remains to be fully elucidated. Here, we discuss the trends in the incidence, detection, treatment, and outcomes of DCIS; along with surveying the literature regarding risk factors known to predispose to this condition.
作者: gangrene    時間: 2025-3-27 15:46

作者: frivolous    時間: 2025-3-27 17:57
Outer Space, War and Sovereigntyg the benefit of screening mammography in the early detection of invasive breast cancer and ductal carcinoma in situ (DCIS) and the numerous recent observational and computer modeling studies that have confirmed this positive effect. Since screening began in the 1980s, mammography has been shown to
作者: FLORA    時間: 2025-3-27 22:31

作者: SEVER    時間: 2025-3-28 04:25
Aminata Diaby,Nicolas Klingelschmittal excisions and needle core biopsies. It discusses the current grading system and it is focused particularly on lesions that are challenging to diagnose in daily pathology practice and that imply different treatment approaches. These topics include atypical ductal hyperplasia (ADH), pleomorphic lob
作者: Audiometry    時間: 2025-3-28 06:49

作者: 中子    時間: 2025-3-28 12:09
Aminata Diaby,Nicolas Klingelschmitte past 40 years. This has prompted a reevaluation of the historic approach to routine management of DCIS via mastectomy. Prospective, randomized clinical trials have now documented the safety of breast-conserving surgery for DCIS and have also revealed benefits of adjuvant endocrine therapy for thes
作者: ostrish    時間: 2025-3-28 18:01

作者: 清楚說話    時間: 2025-3-28 18:55

作者: 使饑餓    時間: 2025-3-29 02:07
Denmark, in situ (DCIS). Over the past few decades, several randomized trials have demonstrated a 50?% reduction in the risk of local recurrence with adjuvant radiotherapy and recent prospective studies demonstrate higher rates of local recurrence with the omission of radiotherapy even in “l(fā)ow-risk” patient
作者: Hla461    時間: 2025-3-29 03:40
ICWES-V, Rouen, France, September 4–8, 1978Targeted molecular therapies have improved outcomes for patients with invasive breast cancer, and we have parallel opportunities for advances in personalized treatment of DCIS. Early work has demonstrated synergy between human epidermal growth factor receptor (HER)2-targeted therapy and radiotherapy
作者: Glaci冰    時間: 2025-3-29 08:34

作者: Infirm    時間: 2025-3-29 12:27

作者: Opponent    時間: 2025-3-29 16:44

作者: 漸變    時間: 2025-3-29 20:01
WebAssembly in?IoT: Beyond Toy Examples 2008; DeSantis et al., CA Cancer J Clin 64:52–62, 2014; Ernster et al., J Natl Cancer Inst 94:1546–1554, 2002). Early detection and a low breast-cancer-specific mortality (1–2?%; Ernster et al., Arch Intern Med 160:953–958, 2000) have resulted in an increasing number of patients that require clinic
作者: 確定    時間: 2025-3-30 00:51
Denmark,to invasive breast cancer, although there are molecular and cellular features that have some predictive power for the development of invasive disease. In women who carry deleterious mutations in the . or other genes, detection of DCIS is paramount, as these women are believed to be at much higher ri
作者: Incompetent    時間: 2025-3-30 04:22
Finland,itu (DCIS). The complex interplay of socioeconomic and biologic factors accounting for these disparities is difficult to disentangle, as racial-ethnic minorities are overrepresented among the impoverished and underinsured/noninsured population of the USA, but African American background has also bee
作者: 門窗的側柱    時間: 2025-3-30 08:24
Lisa A. Newman,Jessica M. BensenhaverProvides challenging and clinically-relevant scenarios.Written by experts in this field.Provides innovative prospects for tailoring the individual patient’s treatment
作者: 完全    時間: 2025-3-30 13:50
http://image.papertrans.cn/e/image/283352.jpg
作者: d-limonene    時間: 2025-3-30 19:58
https://doi.org/10.1007/978-1-4939-2035-8DCIS; SERM therapy; breast tomosynthesis; ultrasonography; surgical oncology
作者: 刺穿    時間: 2025-3-30 22:42

作者: Rinne-Test    時間: 2025-3-31 01:00

作者: 解決    時間: 2025-3-31 06:28

作者: amputation    時間: 2025-3-31 10:52

作者: Working-Memory    時間: 2025-3-31 15:24

作者: patriot    時間: 2025-3-31 21:24

作者: 果仁    時間: 2025-4-1 00:35





歡迎光臨 派博傳思國際中心 (http://pjsxioz.cn/) Powered by Discuz! X3.5
永德县| 尚志市| 烟台市| 图木舒克市| 武强县| 泾川县| 宜君县| 孟津县| 准格尔旗| 扶风县| 板桥市| 定远县| 嘉义县| 武义县| 防城港市| 德惠市| 宁都县| 永寿县| 奈曼旗| 宜章县| 贡嘎县| 平顺县| 新余市| 昭通市| 明光市| 宣恩县| 西畴县| 志丹县| 咸丰县| 张家界市| 布尔津县| 阜新市| 弥渡县| 白朗县| 靖边县| 湘乡市| 满洲里市| 平山县| 科尔| 博乐市| 汉中市|